logo
#

Latest news with #Arch

Arch Manning rumor madness with Nick Saban and Cleveland Browns -- and a whole lot of dumb
Arch Manning rumor madness with Nick Saban and Cleveland Browns -- and a whole lot of dumb

USA Today

time12 hours ago

  • Entertainment
  • USA Today

Arch Manning rumor madness with Nick Saban and Cleveland Browns -- and a whole lot of dumb

We've now reached peak stupidity, which in this day and age, is a true rarity. Let's connect the dots of the nonsensical Arch madness that has officially taken over this college football offseason. Texas quarterback Arch Manning plays well enough in his first season as starter to become the No. 1 pick in the 2026 NFL Draft. Arch is the nephew of NFL Hall of Famer Peyton Manning, who is close friends with Cleveland Browns owner Jimmy Haslam. The Browns have two picks in the first round of the draft, and will trade up (if needed) to select Arch Manning, who has all of 95 career pass attempts. After all that, more dumb enters the speculation: Nick Saban will ignore the love of his life, he beloved bride Ms. Terry, and come out of retirement to coach the Browns and Arch. Now, the kicker: Haslam didn't exactly throw water on the inane thought process, telling media during Browns training camp, 'I think if you know the Manning family, I would bet that – and I don't know Arch at all – I would bet he stays in college two years.' Meanwhile, the unwitting central figure of this bowl of crazy was sitting on the dais earlier this month at SEC Media Days, clearly overwhelmed by an offseason of ridiculous Heisman Trophy hype. 'I didn't ask for any of this,' Manning said, while media crammed eight rows deep around him. I don't want to be the guy to say this, but someone must. All of these dorks pushing Manning narratives will be the same people burying him if he throws a couple of picks in a season-opening loss at Ohio State. ON CAMPUS: What is the best college football stadium? Our top 25 ranking STEPPING UP: Deion Sanders embracin biggest battle of career - cancer This is the lunacy Manning tried to avoid when he left high school as the No.1 overall recruit, a quarterback who just happened to have the football royalty DNA of a grandfather (Archie Manning) and two uncles (Peyton and Eli Manning). He didn't want to play at Georgia or Alabama because he didn't want to be big fish, little pond. He wanted to blend. So he chose Texas and its massive urban campus because it gave him the best opportunity to have a typical college life, to fit in and not stick out. He didn't start for two seasons, played well as a backup starter in a couple off meaningless games, and the next thing you know, the sharps in Vegas make him the favorite to win the 2025 Heisman. Not long after that, he's catching not so subtle strays from Steve Spurrier, who knows a thing or two about playing and coaching the position — and mind games with guys named Manning. Then an enterprising soul at an NFL training camp asked Haslam a ridiculous question to get a 10-second soundbite – because that's where we are now, people – and Haslam throws kerosene on a grease fire. He thinks Manning will play two more seasons of college football, which means Manning wouldn't be available for the Browns to select in the draft. This brilliant deduction from an owner who paid DeShaun Watson $230 million guaranteed — after disturbing off-field problems. More than that, Haslam's refusal to swat the stupidity completely undercut his current team and coach, and a quarterback room that includes Watson, a former bust first round pick signed as a free agent (Kenny Pickett), two selections from the 2025 draft (Dillon Gabriel, Shedeur Sanders) and a 40-something lifer (Joe Flacco). Haslam essentially said we may suck bad enough to earn that No.1 pick, but I don't expect Arch to be around when we're on the clock. The Browns locker room must have loved that. Meanwhile, Texas coach Steve Sarkisian is doing his best to shield Manning from the nonsense, and Manning is doing his best to just be one of the guys. For a program that has one national title in the last 55 years. For a team that was gifted a manageable schedule in its first season in the SEC, a schedule that suddenly looks difficult in Year 2. Manning has thrown 95 passes, everyone. Ninety-five. He has yet to play in a major non-conference game or an SEC road game, or a bitter rivalry game. Yet to stand in the middle of a raucous road environment, be it Ohio Stadium or The Swamp or Sanford Stadium, where he needs a big throw on third and nine. 'Talk is cheap,' Manning said. 'I have to go prove it.' At least someone in this theater of stupidity has his head straight. Matt Hayes is the senior national college football writer for USA TODAY Sports Network. Follow him on X at @MattHayesCFB.

Arch Introduces New Supplemental Health Insurance Products to Help Bridge Coverage Gaps
Arch Introduces New Supplemental Health Insurance Products to Help Bridge Coverage Gaps

Business Wire

time6 days ago

  • Business
  • Business Wire

Arch Introduces New Supplemental Health Insurance Products to Help Bridge Coverage Gaps

HUNT VALLEY, Md.--(BUSINESS WIRE)--Arch Insurance's Accident & Health business unit, a leading provider of both business and consumer insurance products, is pleased to announce the launch of its new Individual Supplemental Health product suite. These products are designed to help individuals manage out-of-pocket expenses not typically covered by major medical plans, including deductibles, co-insurance and out-of-network charges through a variety of benefits including Accident Medical Expense, Hospital Indemnity, Critical Illness and Accidental Death. Arch's products provide an added layer of financial cushion when unexpected health events occur to individuals including employees, independent contractors, gig workers and association members. The products are available with no medical underwriting and are fully portable, allowing policyholders to keep their coverage through job or life changes. Arch's digital technology enables partners to generate quotes and complete enrollments in minutes. Arch's fully licensed call center provides sales and customer service support for both partners and clients. 'By offering access through our APEX™ digital platform or seamless API integration, we're making it easier than ever for our distribution partners to deliver these products efficiently and effectively to their clients,' said Jim Villa, Senior Vice President, Arch Accident & Health. For more information or to schedule a call to discuss how our individual supplemental health products can add value to your company, please visit our website or contact us at accidentandhealth@ About Arch Accident & Health Arch Accident & Health is a leading provider of innovative insurance solutions, committed to redefining industry standards through technological advancements and unparalleled client support. With a focus on excellence and a dedication to delivering value-driven products, Arch Accident & Health continues to lead the way in the insurance sector. About Arch Insurance North America Arch Insurance North America, part of Arch Capital Group Ltd., includes Arch's insurance operations in the United States and Canada. Business in the U.S. is written by Arch Insurance Company, Arch Specialty Insurance Company, Arch Property & Casualty Insurance Company and Arch Indemnity Insurance Company. Business in Canada is written by Arch Insurance Canada Ltd. About Arch Capital Group Ltd. Arch Capital Group Ltd., a publicly listed Bermuda exempted company with approximately $22.1 billion in capital at March 31, 2024, provides insurance, reinsurance and mortgage insurance on a worldwide basis through its wholly owned subsidiaries. Cautionary Note Regarding Forward-Looking Statements The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward−looking statements. This release or any other written or oral statements made by or on behalf of Arch Capital Group Ltd. and its subsidiaries may include forward−looking statements, which reflect the Company's current views with respect to future events and financial performance. All statements other than statements of historical fact included in or incorporated by reference in this release are forward−looking statements. Forward−looking statements can generally be identified by the use of forward−looking terminology such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or their negative or variations or similar terminology. Forward−looking statements involve the Company's current assessment of risks and uncertainties. Actual events and results may differ materially from those expressed or implied in these statements. A non-exclusive list of the important factors that could cause actual results to differ materially from those in such forward-looking statements includes the following: adverse general economic and market conditions; increased competition; pricing and policy term trends; fluctuations in the actions of rating agencies and the Company's ability to maintain and improve its ratings; investment performance; the loss of key personnel; the adequacy of the Company's loss reserves, severity and/or frequency of losses, greater than expected loss ratios and adverse development on claim and/or claim expense liabilities; greater frequency or severity of unpredictable natural and man-made catastrophic events, including the effect of contagious diseases on our business; the impact of acts of terrorism and acts of war; changes in regulations and/or tax laws in the United States or elsewhere; ability to successfully integrate, establish and maintain operating procedures as well as integrate the businesses the Company has acquired or may acquire into the existing operations; changes in accounting principles or policies; material differences between actual and expected assessments for guaranty funds and mandatory pooling arrangements; availability and cost to the Company of reinsurance to manage our gross and net exposures; the failure of others to meet their obligations to the Company; an incident, disruption in operations or other cyber event caused by cyber attacks, the use of artificial intelligence technologies or other technology on the Company's systems or those of the Company's business partners and service providers, which could negatively impact the Company's business and/or expose the Company to litigation; and other factors identified in our filings with the U.S. Securities and Exchange Commission (SEC). The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with other cautionary statements that are included herein or elsewhere. All subsequent written and oral forward−looking statements attributable to us or persons acting on the Company's behalf are expressly qualified in their entirety by these cautionary statements. The Company's forward-looking statements speak only as of the date of this press release or as of the date they are made, and the Company undertakes no obligation to publicly update or revise any forward−looking statement, whether as a result of new information, future events or otherwise. Source — Arch Insurance North America Tag — arch-insurance

Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)
Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)

Toronto Star

time22-07-2025

  • Business
  • Toronto Star

Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)

TORONTO, July 22, 2025 (GLOBE NEWSWIRE) — Arch Biopartners Inc. ('Arch' or the 'Company') (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the investigator-led Phase II trial titled 'Prevention Of NephroToxin Induced Acute Kidney Injury with Cilastatin' (PONTIAK) has commenced patient recruitment at its primary clinical sites in Alberta, Canada. The Phase II PONTIAK study aims to evaluate the efficacy of cilastatin in preventing AKI associated with nephrotoxic pharmaceuticals, which include commonly used drugs such as antibiotics, chemotherapy agents, and imaging dyes, some of which are known to cause kidney damage as a side effect. The trial plans to enrol approximately 698 patients in five hospital sites in Alberta.

'Take the money' for 'squad player' Morris - or keep him?
'Take the money' for 'squad player' Morris - or keep him?

Yahoo

time19-07-2025

  • Sport
  • Yahoo

'Take the money' for 'squad player' Morris - or keep him?

We asked for your views on Shayden Morris being linked with a move to Luton Town, and whether or not you would like to keep him or see him go. Here's what some of you said: Steve: Most Aberdeen fans would agree that we'd like Morris to stay. But, I don't think we as fans can influence the Aberdeen board or manager in a situation like this. Just look at last season with Bojan Miovski. Every player has his price, some more valuable than others. Does Morris himself see his future away from Aberdeen, or will he try and hold Aberdeen to ransom by informing them he won't sign another contract? Then again, do you take the money and run, then buy a replacement with the proceeds of his transfer? With what will be a difficult season ahead, Europe and domestic football to cope with, it will be a very difficult decision the Aberdeen hierarchy have to make. Allan: If you can get close to £1m for what effectively is a semi-decent squad player, and considering we have a few more speedy wingers, I would say thanks for your efforts and take the money. Arch: It would be good to keep such a talented player but a shame to lose him for nothing next year. He's too good for League One, so Luton are unlikely to reach a sensible offer. However, others with more realistic ambitions and budgets will probably want him. He'll probably go somewhere, the board just have to get the right price. David: Take the money! Morris had a good season but he's a one-trick pony and teams will have worked out how to stop him. He wasn't a regular starter and is unlikely to be one this season either. The money will be useful in the search for a decent striker. Malky: The curious case of Shady Mo. Shayden is clearly a confident player, a man who Neil Warnock embarrassed, and perhaps rightly so at the time. He is now somewhat of a hero. I would hate to see him leave, there's a player there who can make the difference, but is he a 90-minute player yet? You would have to say no, but he most definitely has the potential. I would hope the club are only moving on players for the correct price. For me, we still need him and I would hope he signs a contract instead of moving on. I know there's still time, but I'm slightly more concerned about our lack of additions up front. We can't just go into the season with Ester Sokler and Kusini Yengi! Chris: I don't think we should sell him. Let him have another season scoring goals and setting up chances, then maybe he'll be worth lots more.

'Take the money' for 'squad player' Morris - or keep him?
'Take the money' for 'squad player' Morris - or keep him?

BBC News

time19-07-2025

  • Sport
  • BBC News

'Take the money' for 'squad player' Morris - or keep him?

We asked for your views on Shayden Morris being linked with a move to Luton Town, and whether or not you would like to keep him or see him what some of you said:Steve: Most Aberdeen fans would agree that we'd like Morris to stay. But, I don't think we as fans can influence the Aberdeen board or manager in a situation like this. Just look at last season with Bojan Miovski. Every player has his price, some more valuable than others. Does Morris himself see his future away from Aberdeen, or will he try and hold Aberdeen to ransom by informing them he won't sign another contract? Then again, do you take the money and run, then buy a replacement with the proceeds of his transfer? With what will be a difficult season ahead, Europe and domestic football to cope with, it will be a very difficult decision the Aberdeen hierarchy have to If you can get close to £1m for what effectively is a semi-decent squad player, and considering we have a few more speedy wingers, I would say thanks for your efforts and take the It would be good to keep such a talented player but a shame to lose him for nothing next year. He's too good for League One, so Luton are unlikely to reach a sensible offer. However, others with more realistic ambitions and budgets will probably want him. He'll probably go somewhere, the board just have to get the right Take the money! Morris had a good season but he's a one-trick pony and teams will have worked out how to stop him. He wasn't a regular starter and is unlikely to be one this season either. The money will be useful in the search for a decent The curious case of Shady Mo. Shayden is clearly a confident player, a man who Neil Warnock embarrassed, and perhaps rightly so at the time. He is now somewhat of a hero. I would hate to see him leave, there's a player there who can make the difference, but is he a 90-minute player yet? You would have to say no, but he most definitely has the potential. I would hope the club are only moving on players for the correct price. For me, we still need him and I would hope he signs a contract instead of moving on. I know there's still time, but I'm slightly more concerned about our lack of additions up front. We can't just go into the season with Ester Sokler and Kusini Yengi!Chris: I don't think we should sell him. Let him have another season scoring goals and setting up chances, then maybe he'll be worth lots more.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store